Invention Grant
- Patent Title: CDK inhibitors
-
Application No.: US17922804Application Date: 2021-05-04
-
Publication No.: US12285429B2Publication Date: 2025-04-29
- Inventor: Zhilong Hu , Hu He , Fei Zhang , Wenge Zhong , Xiaotian Zhu
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Norton Rose Fulbright US LLP
- Priority: WOPCT/CN2020/088585 20200505
- International Application: PCT/US2021/030728 WO 20210504
- International Announcement: WO2021/226140 WO 20211111
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/506 ; A61K31/5377 ; A61K31/55 ; A61K45/06 ; A61P35/00 ; C07D405/14 ; C07D487/04
Abstract:
The invention provides a compound represented by the either of the following structural formulas, or a pharmaceutically acceptable salt, or a stereoisomer thereof, useful for treating cancer.
Public/Granted literature
- US20230174512A1 CDK INHIBITORS Public/Granted day:2023-06-08
Information query
